L. E. James

592 total citations
10 papers, 436 citations indexed

About

L. E. James is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, L. E. James has authored 10 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in L. E. James's work include Cancer therapeutics and mechanisms (5 papers), Lung Cancer Research Studies (5 papers) and Neuroendocrine Tumor Research Advances (4 papers). L. E. James is often cited by papers focused on Cancer therapeutics and mechanisms (5 papers), Lung Cancer Research Studies (5 papers) and Neuroendocrine Tumor Research Advances (4 papers). L. E. James collaborates with scholars based in United Kingdom, Ireland and United States. L. E. James's co-authors include N.H. Gower, SG Spiro, R.M. Rudd, M C Ruiz de Elvira, P. Harper, Alan Lamont, R L Souhami, Siow Ming Lee, W. Qian and R.M. Rudd and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Annals of Oncology.

In The Last Decade

L. E. James

10 papers receiving 420 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. E. James United Kingdom 8 301 189 158 127 38 10 436
M.C. Berchier Belgium 14 363 1.2× 281 1.5× 161 1.0× 132 1.0× 3 0.1× 26 479
Frédéric Bigot France 9 220 0.7× 140 0.7× 20 0.1× 52 0.4× 15 0.4× 33 356
Osamu Nakahara Japan 13 232 0.8× 133 0.7× 52 0.3× 46 0.4× 4 0.1× 42 392
Judit Kocsis Hungary 9 164 0.5× 79 0.4× 14 0.1× 87 0.7× 7 0.2× 38 341
Çağlayan Geredeli Türkiye 10 210 0.7× 108 0.6× 35 0.2× 52 0.4× 3 0.1× 49 304
H Karnicka-Młodkowska Poland 9 391 1.3× 202 1.1× 225 1.4× 99 0.8× 24 464
Guochen Duan China 9 234 0.8× 93 0.5× 35 0.2× 25 0.2× 3 0.1× 30 323
Takahito Taniura Japan 12 246 0.8× 160 0.8× 32 0.2× 26 0.2× 4 0.1× 25 403
Yakup Bozkaya Türkiye 10 172 0.6× 84 0.4× 41 0.3× 33 0.3× 2 0.1× 35 285
Şeyda Gündüz Türkiye 9 185 0.6× 76 0.4× 21 0.1× 31 0.2× 4 0.1× 15 251

Countries citing papers authored by L. E. James

Since Specialization
Citations

This map shows the geographic impact of L. E. James's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. E. James with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. E. James more than expected).

Fields of papers citing papers by L. E. James

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. E. James. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. E. James. The network helps show where L. E. James may publish in the future.

Co-authorship network of co-authors of L. E. James

This figure shows the co-authorship network connecting the top 25 collaborators of L. E. James. A scholar is included among the top collaborators of L. E. James based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. E. James. L. E. James is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Ledermann, Jonathan A., Gordon Rustin, A. Hackshaw, et al.. (2009). A randomized phase II placebo-controlled trial using maintenance therapy to evaluate the vascular targeting agent BIBF 1120 following treatment of relapsed ovarian cancer (OC). Journal of Clinical Oncology. 27(15_suppl). 5501–5501. 32 indexed citations
2.
Lee, Siow Ming, L. E. James, W. Qian, et al.. (2008). Comparison of gemcitabine and carboplatin versus cisplatin and etoposide for patients with poor-prognosis small cell lung cancer. Thorax. 64(1). 75–80. 48 indexed citations
3.
Lee, Siow Ming, R.M. Rudd, Penella J. Woll, et al.. (2008). Two randomised phase III, double blind, placebo controlled trials of thalidomide in patients with advanced non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Journal of Clinical Oncology. 26(15_suppl). 8045–8045. 9 indexed citations
4.
Ledermann, Jonathan A., Hani Gabra, Gordon C. Jayson, et al.. (2007). 5031 POSTER Combination chemotherapy with carboplatin and gemcitabine in patients in platinum-resistant ovarian cancer chemotherapy: a phase II study demonstrating inhibition of DNA cross-link repair by gemcitabine. European Journal of Cancer Supplements. 5(4). 320–320. 1 indexed citations
5.
Payne, John, Kyriacos I. Eleftheriou, L. E. James, et al.. (2006). Left ventricular growth response to exercise and cigarette smoking: data from LARGE Heart. Heart. 92(12). 1784–1788. 20 indexed citations
6.
7.
James, L. E., et al.. (2003). Open treatment of anterior impingement of the ankle. Journal of Bone and Joint Surgery - British Volume. 85-B(4). 550–553. 37 indexed citations
8.
Souhami, R L, SG Spiro, R.M. Rudd, et al.. (1997). Five-Day Oral Etoposide2 Treatment for Advanced Small-Cell Lung Cancer: Randomized Comparison With Intravenous Chemotherapy. JNCI Journal of the National Cancer Institute. 89(8). 577–580. 143 indexed citations
9.
10.
Gower, N.H., R.M. Rudd, M C Ruiz de Elvira, et al.. (1995). Assessment of ’quality of life’ using a daily diary card in a randomised trial of chemotherapy in small-cell lung cancer. Annals of Oncology. 6(6). 575–580. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M.C. Berchier Breakdown of academic impact, for papers by Frédéric Bigot Breakdown of academic impact, for papers by Osamu Nakahara Breakdown of academic impact, for papers by Judit Kocsis Breakdown of academic impact, for papers by Çağlayan Geredeli Breakdown of academic impact, for papers by H Karnicka-Młodkowska Breakdown of academic impact, for papers by Guochen Duan Breakdown of academic impact, for papers by Takahito Taniura Breakdown of academic impact, for papers by Yakup Bozkaya Breakdown of academic impact, for papers by Şeyda Gündüz
Rankless by CCL
2026